LIFESTANCE HEALTH GROUP INC (LFST) Stock Fundamental Analysis
USA - NASDAQ:LFST - US53228F1012 - Common Stock
6.44 USD
-0.03 (-0.46%)
6.51 USD
+0.07 (+1.09%)
Overall LFST gets a fundamental rating of 3 out of 10. We evaluated LFST against 100 industry peers in the Health Care Providers & Services industry. LFST scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LFST is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year LFST has reported negative net income.
In the past year LFST had a positive cash flow from operations.
In the past 5 years LFST always reported negative net income.
In multiple years LFST reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of LFST (-0.75%) is comparable to the rest of the industry.
With a Return On Equity value of -1.10%, LFST perfoms like the industry average, outperforming 54.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | -1.1% | ||
| ROIC | N/A |
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
LFST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
LFST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFST has more shares outstanding
LFST has more shares outstanding than it did 5 years ago.
The debt/assets ratio for LFST is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.39 indicates that LFST is not a great score, but indicates only limited risk for bankruptcy at the moment.
LFST has a Altman-Z score (2.39) which is in line with its industry peers.
The Debt to FCF ratio of LFST is 2.36, which is a good value as it means it would take LFST, 2.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LFST (2.36) is better than 79.00% of its industry peers.
LFST has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.19, LFST is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 2.36 | ||
| Altman-Z | 2.39 |
ROIC/WACCN/A
WACC9.31%
2.3 Liquidity
A Current Ratio of 1.48 indicates that LFST should not have too much problems paying its short term obligations.
LFST has a Current ratio (1.48) which is comparable to the rest of the industry.
LFST has a Quick Ratio of 1.48. This is a normal value and indicates that LFST is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.48, LFST perfoms like the industry average, outperforming 59.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 88.46% over the past year.
LFST shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.50%.
Measured over the past years, LFST shows a very strong growth in Revenue. The Revenue has been growing by 42.55% on average per year.
EPS 1Y (TTM)88.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)18.5%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%16.34%
3.2 Future
Based on estimates for the next years, LFST will show a very strong growth in Earnings Per Share. The EPS will grow by 46.80% on average per year.
The Revenue is expected to grow by 12.39% on average over the next years. This is quite good.
EPS Next Y80.88%
EPS Next 2Y50.17%
EPS Next 3Y46.8%
EPS Next 5YN/A
Revenue Next Year14.25%
Revenue Next 2Y14.19%
Revenue Next 3Y14.5%
Revenue Next 5Y12.39%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LFST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 157.84, LFST can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, LFST is valued a bit more expensive than the industry average as 64.00% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of LFST to the average of the S&P500 Index (34.43), we can say LFST is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 157.84 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as LFST.
Based on the Price/Free Cash Flow ratio, LFST is valued a bit cheaper than 63.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.86 | ||
| EV/EBITDA | 45.44 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LFST's earnings are expected to grow with 46.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.17%
EPS Next 3Y46.8%
5. Dividend
5.1 Amount
No dividends for LFST!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.44
-0.03 (-0.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners38%
Inst Owner Change-1.03%
Ins Owners3%
Ins Owner Change-8.79%
Market Cap2.50B
Revenue(TTM)1.25B
Net Income(TTM)-16.15M
Analysts84.29
Price Target8.5 (31.99%)
Short Float %4.23%
Short Ratio3.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.66%
Min EPS beat(2)67.32%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)70.6%
Min EPS beat(4)43.98%
Max EPS beat(4)100%
EPS beat(8)6
Avg EPS beat(8)24.17%
EPS beat(12)9
Avg EPS beat(12)15.58%
EPS beat(16)9
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.94%
Max Revenue beat(2)-1.93%
Revenue beat(4)2
Avg Revenue beat(4)-0.21%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)6
Avg Revenue beat(12)0.34%
Revenue beat(16)7
Avg Revenue beat(16)-0.16%
PT rev (1m)-1.13%
PT rev (3m)0.25%
EPS NQ rev (1m)-50.06%
EPS NQ rev (3m)-25%
EPS NY rev (1m)-23.51%
EPS NY rev (3m)38.46%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.79%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 157.84 | ||
| P/S | 1.9 | ||
| P/FCF | 20.86 | ||
| P/OCF | 17.09 | ||
| P/B | 1.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 45.44 |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.04
Fwd EY0.63%
FCF(TTM)0.31
FCFY4.79%
OCF(TTM)0.38
OCFY5.85%
SpS3.38
BVpS3.79
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.75% | ||
| ROE | -1.1% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | 9.12% |
ROA(3y)-7.15%
ROA(5y)-11.83%
ROE(3y)-10.4%
ROE(5y)-16.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 2.36 | ||
| Debt/EBITDA | 4.75 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.01% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 255.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.48 | ||
| Altman-Z | 2.39 |
F-Score7
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)65.1%
Cap/Depr(5y)98.49%
Cap/Sales(3y)4.93%
Cap/Sales(5y)7.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y80.88%
EPS Next 2Y50.17%
EPS Next 3Y46.8%
EPS Next 5YN/A
Revenue 1Y (TTM)18.5%
Revenue growth 3Y23.29%
Revenue growth 5Y42.55%
Sales Q2Q%16.34%
Revenue Next Year14.25%
Revenue Next 2Y14.19%
Revenue Next 3Y14.5%
Revenue Next 5Y12.39%
EBIT growth 1Y99.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year441.48%
EBIT Next 3Y95.15%
EBIT Next 5YN/A
FCF growth 1Y1147.77%
FCF growth 3YN/A
FCF growth 5Y99.09%
OCF growth 1Y339.74%
OCF growth 3Y124.97%
OCF growth 5Y44.46%
LIFESTANCE HEALTH GROUP INC / LFST FAQ
What is the fundamental rating for LFST stock?
ChartMill assigns a fundamental rating of 3 / 10 to LFST.
What is the valuation status of LIFESTANCE HEALTH GROUP INC (LFST) stock?
ChartMill assigns a valuation rating of 2 / 10 to LIFESTANCE HEALTH GROUP INC (LFST). This can be considered as Overvalued.
What is the profitability of LFST stock?
LIFESTANCE HEALTH GROUP INC (LFST) has a profitability rating of 1 / 10.